Author:
Leopold Christine,Mantel-Teeuwisse Aukje Katja,Vogler Sabine,de Joncheere Kees,Laing Richard Ogilvie,Leufkens Hubert G.M.
Funder
Netherlands Organisation for Health Research and Development (ZonMW)
Dutch Health Care Insurance Board (CVZ), the Royal Dutch Pharmacists Association (KNMP)
Top Institute Pharma
EU Innovative Medicines Initiative (IMI), EU 7th Framework Program (FP7)
Dutch Medicines Evaluation Board, the Dutch Ministry of Health and Industry
Reference39 articles.
1. Pharmaceutical expenditure. As percentage of total expenditure on health;OECD;Health: Key Tables from OECD,2013
2. Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States;Vogler;Croatian Medical Journal,2011
3. Drugs and Money. Prices affordability and cost containment;Dukes,2003
4. Pharmaceutical Pricing and Reimbursement Information (PPRI) Final Report;Vogler,2007
5. Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality;Mossialos,2004
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献